← Leaderboards

Matthias Egger

Universitat Bern

Google Scholar ↗PubMed ↗ORCID ↗

$29,882,883

Attributed

$49,349,558

Total exposure

2

Grants

2

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $5.1M · FY2006–24

$10M$7.5M$5M$2.5M$0

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$49,349,558 · 2

By mechanism

U01$46,887,928 · 1

R01$2,461,630 · 1

Top collaborators

Mary-Ann Davies16 shared

Most similar at Universitat Bern

Same institution · by research overlap

Mary-Ann Davies$23,063,103
Cleophas Chimbetete$1,484,109
Eliane Rohner$1,484,109
Gilles Wandeler$1,484,109

Others in their field

Top investigators on “Acquired Immunodeficiency Syndrome”

David Heimbrook · Leidos Biomedical Research, Inc.$300,790,583
George R Seage · Abt Associates, Inc.$244,444,207
Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$180,045,219
Barbara Driver · Westat, Inc.$168,632,670
Michelle Vargas · Ppd Development Lp$163,846,102
Judith S. Currier · University Of California Los Angeles$150,146,659

Research focus

Acquired Immunodeficiency SyndromeMonitorCohortAdultCountryEpidemiologyChildPregnant WomenTuberculosisAntiretroviral TherapyAnti-Retroviral AgentsPharmaceutical PreparationsCollaborationsExposure ToDatabasesSouth AfricaEpidemicSouthern AfricaFollow-UpAdolescentTreatment ProgramInternationalRegimenPrevalence

Grant awards (28)

HIV-1 subtype, specific drug resistance in patients failing Dolutegravir-based 1st, 2nd or 3rd line regimens: the International epidemiological Databases to Evaluate AIDS (IeDEA)$844,255

R01 · FY2024 · AI · contact PI

Modeling the impact of cervical cancer prevention in Zambia$59,745

U01 · FY2024 · AI · contact PI

International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa.$3,380,907

U01 · FY2023 · AI · contact PI

HIV-1 subtype, specific drug resistance in patients failing Dolutegravir-based 1st, 2nd or 3rd line regimens: the International epidemiological Databases to Evaluate AIDS (IeDEA)$61,217

R01 · FY2023 · AI · contact PI

International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa.$4,063,852

U01 · FY2022 · AI · contact PI

HIV-1 subtype, specific drug resistance in patients failing Dolutegravir-based 1st, 2nd or 3rd line regimens: the International epidemiological Databases to Evaluate AIDS (IeDEA)$1,075,525

R01 · FY2022 · AI · contact PI

International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa.$3,400,000

U01 · FY2021 · AI · contact PI

HIV-1 subtype, specific drug resistance in patients failing Dolutegravir-based 1st, 2nd or 3rd line regimens: the International epidemiological Databases to Evaluate AIDS (IeDEA)$480,633

R01 · FY2021 · AI · contact PI

International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA)$3,068,837

U01 · FY2020 · AI · contact PI

International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA)$67,927

U01 · FY2020 · AI · contact PI

International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA)$3,000,683

U01 · FY2019 · AI · contact PI

International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA)$2,531,588

U01 · FY2018 · AI · contact PI

International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA)$3,025,969

U01 · FY2017 · AI · contact PI

International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA)$2,500,000

U01 · FY2016 · AI · contact PI

International Epidemiologic Databases to Evaluate AIDS-Southern Africa (IeDEA-SA)$1,967,643

U01 · FY2015 · AI · contact PI

International Epidemiologic Databases to Evaluate AIDS-Southern Africa (IeDEA-SA)$290,667

U01 · FY2015 · AI · contact PI

International Epidemiologic Databases to Evaluate AIDS-Southern Africa (IeDEA-SA)$2,547,506

U01 · FY2014 · AI · contact PI

International Epidemiologic Databases to Evaluate AIDS-Southern Africa (IeDEA-SA)$2,789,548

U01 · FY2013 · AI · contact PI

International Epidemiologic Databases to Evaluate AIDS-Southern Africa (IeDEA-SA)$3,868,346

U01 · FY2012 · AI · contact PI

International Epidemiologic Databases to Evaluate AIDS-Southern Africa (IeDEA-SA)$2,370,132

U01 · FY2011 · AI · contact PI

Observational Antiretroviral Studies In Southern Africa (OASIS) Collaboration$1,603,384

U01 · FY2010 · AI · contact PI

Observational Antiretroviral Studies In Southern Africa (OASIS) Collaboration$413,807

U01 · FY2010 · AI · contact PI

Observational Antiretroviral Studies In Southern Africa (OASIS) Collaboration$57,706

U01 · FY2010 · AI · contact PI

Observational Antiretroviral Studies In Southern Africa (OASIS) Collaboration$1,835,578

U01 · FY2009 · AI · contact PI

Observational Antiretroviral Studies In Southern Africa (OASIS) Collaboration$1,477,358

U01 · FY2008 · AI · contact PI

Observational Antiretroviral Studies In Southern Africa (OASIS) Collaboration$1,326,850

U01 · FY2007 · AI · contact PI

Observational Antiretroviral Studies In Southern Africa (OASIS) Collaboration$109,480

U01 · FY2007 · AI · contact PI

Observational Antiretroviral Studies In Southern Africa (OASIS) Collaboration$1,130,415

U01 · FY2006 · AI · contact PI